1. Market Research
  2. > Healthcare Market Trends

Health care System Development in Kenya and Rwanda : Unlocking New Opportunities in Sub-Saharan Africa

  • April 2015
  • 103 pages
  • Frost & Sullivan
Report ID: 2841918

Summary

Table of Contents

Key Findings

•Health care is regarded as the 4th most-attractive investment sector in Africa. Economic factors and the regulatory environment are the key aspects companies take into consideration when evaluating new markets.
•The increased prevalence of chronic diseases, the rising income levels, and the augmented health awareness drive the upsurge in the per capita total health expenditure in Kenya and Rwanda.
•More than x % of the total mobile penetration, along with ICT infrastructure and connectivity, will be the backbone of new mobile applications and mHealth startups in Kenya and Rwanda.
•Kenya has the most developed economy in East Africa. From 2004 to 2014, the country’s GDP averaged x %. However, due to lack of proper facilities, about x medical tourism patients from Kenya travel abroad each year, according to the Kenya Bureau of Statistics.
•HIV/AIDS is the major cause of adult death in Kenya. Effective low-cost point-of-care (POC) HIV diagnostic kits for nucleic acid testing (NAT) and immunodiagnostics hold potential as around 60% of the population live in rural areas without proper access to care.
•Around 60% of the total pregnancies in Kenya are handled by the private sector.
•According to the World Bank, in Kenya, out-of-pocket (OOP) expenses account for $ x out of every $ x spent on private health care. Annual private health care investments in East Africa grew by an average of x %, each year, from 2003 to 2013.
•In Rwanda, patients are often in the late stage of severe disease when they approach x of the x academic referral hospitals.
•The health transformation in Rwanda over the last x years was enabled, to a large extent, by community health workers (CHWs) who offer a solution to the financial, geographical, and infrastructural barriers in the resource-constrained country, thereby improving access to health in rural communities.
•Rwanda's per capita total expenditure on health has increased by more than x % between x and 2012.
•Although the number of health facilities in the country has increased over the past decade, approximately x % of the patients still travel more than x km to reach the closest facility. Physicians lack both the equipment and the training to provide specialized care.
•At the national level, the procurement and the distribution of drugs and medical supplies have made progress; however, the same cannot be said about the intermediate and the peripheral levels.
•By the end of 2017, Rwanda aims to provide 4G LTE technology to x % of its population.
•More than half of the country’s total health expenditure is funded by external resources. The salaries of doctors and nurses have been cut by x % due to the decrease in external assistance post 2011. Community-based national health insurance schemes do not include coverage at private health centres.
•Rwanda continues to be the most densely populated country in Africa with x persons living per square km. The high population growth rate is creating a huge demand for health care infrastructure.
•The formation of the East Africa Community (EAC) could provide opportunities for the insurance companies in the region.

Health care System

•From 2000 to 2013, Rwanda was the fastest-growing African nation with a yearly growth average of x %.
•The Ministry of Health (MoH) has started a public health scheme and set up training institutes, such as the Kigali Health Institute (KHI) and the College of Medicine and Health Sciences, University of Rwanda, Butare.
•In 2013, x % of the population was covered under public health insurance. The MoH is the major provider of primary, secondary, tertiary, and preventive health services.
•To improve the current situation, the government has increased national expenditure on health care by around x % (from 1996 to 2013). Over the same period, Rwanda was able to drastically reduce mortality rates due to diarrhoea ( x %) and maternal/neo-natal conditions ( x %).
•Rwanda’s health profile remains dominated by communicable diseases. The World Health Organization (WHO) classifies the HIV/AIDS prevalence in Rwanda as a generalized epidemic with a current prevalence of x % for the total population aged x x , which has declined from x % in 2004.
•There is a serious shortage of health care professionals in the country, with only x doctors and x paramedics per x people.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Amrita helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

2017 World Blood Typing, Grouping and Infectious Disease Screening Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 43500
  • Industry report
  • January 2017
  • by Venture Planning Group

This comprehensive 68-country report from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market ...

2017 World Transfusion Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 43500
  • Industry report
  • January 2017
  • by Venture Planning Group

This comprehensive 68-country report from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market ...

Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Market 2021: A 68-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 43500
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 68-country report from VPGMarketResearch.com is available by region, country, market segment, section, or individual test. The report is designed to help current suppliers and potential market ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.